The Renal Drug Handbook, 3rd Edition

Product Information

individual medicine monographs on how to prescribe, prepare and administer the medicine in various types of renal impairment provide a practice-based review of drug utilisation in renal units across the UK indicating, where appropriate, any local methods of use, licensed or otherwise.

Biologics, Biosimilars and Biobetters: An Introduction for Pharmacists, Physicians and other Health Practitioners(2021) contains pharmacokinetic data to inform how the medicine will be removed, e.g. amount of parent medicine excreted through the kidneys, how any active metabolites are removed, impact of kidney disease on medication half-life The use of drugs in patients with impaired renal function can give rise to problems for several reasons: provide healthcare professionals with a single reference of easily retrievable, practical information relating to drug use, sourced from the practical experience of renal units throughout the UK. By referring to the monographs, the user is guided in how to prescribe, prepare and administer the drug with due regard to potentially serious drug interactions and to any renal replacement therapy the patient may be undergoing. Launched in 2014, The Renal Drug Database comprises all monograph information from the highly successful The Renal Drug Handbook, the universally-trusted resource for pharmacists seeking definitive prescribing information when treating patients with renal impairment.Many of these problems can be avoided by careful choice and use of drugs. The Renal Drug Database seeks to assist healthcare professionals in this process. For many drugs, some or even all of the altered pharmacokinetic parameters and modified interrelationships are unknown. In such circumstances, the informed professional judgement of clinicians and pharmacists must be used to predict drug disposition. This must be based on knowledge of the drug, its class, chemistry and pharmacokinetics in patients with normal renal function. CRC Press publishes medical books across a wide range of therapy areas including Toxicology, Pharmaceutical Science, Infectious Disease, Oncology, Nephrology, Gastroenterology and Hepatology. CRC Press authors and editors are among the leaders in medical science, and many of our publications document the notable contributions they have made to their own specialist fields. You can find details about all our books by visiting https://www.crcpress.com/medicine

Altered pharmacokinetics of some drugs, i.e. changes in absorption, tissue distribution, extent of plasma protein binding, metabolism and excretion. In renal impairment these parameters are often variable and interrelated in a complex manner. This may be further complicated if the patient is undergoing renal replacement therapy. Caroline Ashley is the Lead Specialist Pharmacist for Renal Services at the University College London Centre for Nephrology and Transplantation at the Royal Free Hospital. She has over 25 years' experience, with major interests in transplantation and auto-immune renal disease. Caroline was involved in the development of the Renal National Service Framework, and the NICE Guidelines on Immunosuppression in Renal Transplantation, Renal Anaemia and Acute Kidney Injury. She is the co-editor of The Renal Drug Handbook, The Renal Drug Database and The Introduction to Renal Therapeutics and sits on the editorial board of the British Journal of Renal Medicine. She was Chair of the Uk Renal Pharmacy Group from 1996 to 2016, and was made Associate Professor of Pharmacy Practice, UCL School of Pharmacy in 2011. Welcome to the The Renal Drug Database. The information contained in this resource has been compiled from a wide range of sources and from the clinical experience of the editorial board of the UK Renal Pharmacy Group, all of whom are involved in the pharmaceutical care of renally-impaired patients. As such, some of the information contained in the monographs may not be in accordance with the licensed indications or use of the drug.

One of our top member benefits!

Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) the kidney function expressed as estimated glomerular filtration rate (eGFR) normalised to a body surface area of 1.73m 2